{"AllianceGenome": "3263", "HGNC": "3263", "MIM": "606229", "_id": "27161", "_version": 2, "accession": {"genomic": ["AC067931.16", "AC107375.5", "CH471060.1", "CP068270.2", "CS300529.1", "NC_000008.11", "NC_060932.1"], "protein": ["AAF13034.2", "AAH07633.1", "AAH18727.2", "AAI25214.1", "AAL76093.1", "AAP35893.1", "CAK32193.1", "EAW92207.1", "EAW92208.1", "NP_001158095.1", "NP_036286.2", "Q9UKV8.3", "XP_011515267.1", "XP_011515270.3", "XP_047277651.1", "XP_047277652.1", "XP_047277653.1", "XP_054216272.1", "XP_054216273.1", "XP_054216274.1", "XP_054216275.1", "XP_054216276.1"], "rna": ["AA909234.1", "AF121255.2", "AI468419.1", "AK092172.1", "AK096164.1", "AK130012.1", "AL050151.1", "AY077717.1", "BC007633.1", "BC018727.1", "BC033700.1", "BC054491.1", "BC065217.1", "BC125213.1", "BC125214.1", "BT007229.1", "NM_001164623.3", "NM_012154.5", "XM_011516965.3", "XM_011516968.3", "XM_047421695.1", "XM_047421696.1", "XM_047421697.1", "XM_054360297.1", "XM_054360298.1", "XM_054360299.1", "XM_054360300.1", "XM_054360301.1"], "translation": [{"protein": "XP_011515267.1", "rna": "XM_011516965.3"}, {"protein": "XP_054216272.1", "rna": "XM_054360297.1"}, {"protein": "XP_011515270.3", "rna": "XM_011516968.3"}, {"protein": "AAH07633.1", "rna": "BC007633.1"}, {"protein": "XP_054216274.1", "rna": "XM_054360299.1"}, {"protein": "NP_001158095.1", "rna": "NM_001164623.3"}, {"protein": "XP_054216276.1", "rna": "XM_054360301.1"}, {"protein": "XP_054216273.1", "rna": "XM_054360298.1"}, {"protein": "XP_054216275.1", "rna": "XM_054360300.1"}, {"protein": "AAH18727.2", "rna": "BC018727.1"}, {"protein": "AAL76093.1", "rna": "AY077717.1"}, {"protein": "AAP35893.1", "rna": "BT007229.1"}, {"protein": "XP_047277652.1", "rna": "XM_047421696.1"}, {"protein": "NP_036286.2", "rna": "NM_012154.5"}, {"protein": "XP_047277651.1", "rna": "XM_047421695.1"}, {"protein": "AAF13034.2", "rna": "AF121255.2"}, {"protein": "AAI25214.1", "rna": "BC125213.1"}, {"protein": "XP_047277653.1", "rna": "XM_047421697.1"}]}, "alias": ["CASC7", "EIF2C2", "LESKRES", "LINC00980", "PPD", "Q10"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2023-09-15T16:00:00.000Z", "disease_label": "Lessel-Kreienkamp syndrome", "gcep": "Syndromic Disorders Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0030897", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_ec86c06a-f5a3-448d-be53-277bc91d12de-2023-09-15T160000.000Z", "sop": "SOP10"}}, "ec": "3.1.26.n2", "ensembl": {"gene": "ENSG00000123908", "protein": ["ENSP00000220592", "ENSP00000430164", "ENSP00000430176", "ENSP00000431056"], "transcript": ["ENST00000220592", "ENST00000517293", "ENST00000518019", "ENST00000519347", "ENST00000519980", "ENST00000520412", "ENST00000520628", "ENST00000521325", "ENST00000523609", "ENST00000524328"], "translation": [{"protein": "ENSP00000220592", "rna": "ENST00000220592"}, {"protein": "ENSP00000430176", "rna": "ENST00000519980"}, {"protein": "ENSP00000430164", "rna": "ENST00000523609"}, {"protein": "ENSP00000431056", "rna": "ENST00000524328"}], "type_of_gene": "protein_coding"}, "entrezgene": "27161", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 32.7366089685, "exp_mis": 396.190514951, "exp_syn": 204.177157006, "lof_z": 5.66769596543799, "mis_z": 7.69614089655119, "mu_lof": 2.32584034872e-06, "mu_mis": 3.60232018966e-05, "mu_syn": 1.82983643166e-05, "n_lof": 0.0, "n_mis": 83.0, "n_syn": 176.0, "p_li": 0.999992248962312, "p_null": 7.63427680807739e-14, "p_rec": 7.75103761200044e-06, "syn_z": 1.22248544215258}, "bp": 2580, "cds_end": 141645605, "cds_start": 141542142, "n_exons": 19, "nonpsych": {"exp_lof": 29.2659925276, "exp_mis": 358.2268604, "exp_syn": 184.436229011, "lof_z": 5.31292373131101, "mis_z": 7.62769021825331, "mu_lof": 2.32584034872e-06, "mu_mis": 3.60232018966e-05, "mu_syn": 1.82983643166e-05, "n_lof": 0.0, "n_mis": 72.0, "n_syn": 158.0, "p_li": 0.999975217690356, "p_null": 1.57948552198547e-12, "p_rec": 2.47823080649942e-05, "syn_z": 1.22557371762514}, "nontcga": {"exp_lof": 30.0822206261, "exp_mis": 364.459839229, "exp_syn": 187.807528308, "lof_z": 5.41048492015963, "mis_z": 7.58003232851986, "mu_lof": 2.32584034872e-06, "mu_mis": 3.60232018966e-05, "mu_syn": 1.82983643166e-05, "n_lof": 0.0, "n_mis": 74.0, "n_syn": 169.0, "p_li": 0.99997991850296, "p_null": 7.7439686456256e-13, "p_rec": 2.00814962656969e-05, "syn_z": 0.868954276860196}, "transcript": "ENST00000220592.5"}, "exons": [{"cdsend": 140635506, "cdsstart": 140532043, "chr": "8", "position": [[140520155, 140532152], [140532415, 140532615], [140539319, 140539454], [140541163, 140541358], [140544212, 140544303], [140547467, 140547627], [140549113, 140549298], [140551302, 140551436], [140555895, 140556018], [140556166, 140556286], [140557088, 140557236], [140558484, 140558572], [140559394, 140559529], [140560373, 140560510], [140562452, 140562634], [140572811, 140572932], [140585118, 140585311], [140635484, 140635633]], "strand": -1, "transcript": "NM_001164623", "txend": 140635633, "txstart": 140520155}, {"cdsend": 140635506, "cdsstart": 140532043, "chr": "8", "position": [[140520155, 140532152], [140532415, 140532615], [140535467, 140535569], [140539319, 140539454], [140541163, 140541358], [140544212, 140544303], [140547467, 140547627], [140549113, 140549298], [140551302, 140551436], [140555895, 140556018], [140556166, 140556286], [140557088, 140557236], [140558484, 140558572], [140559394, 140559529], [140560373, 140560510], [140562452, 140562634], [140572811, 140572932], [140585118, 140585311], [140635484, 140635633]], "strand": -1, "transcript": "NM_012154", "txend": 140635633, "txstart": 140520155}], "exons_hg19": [{"cdsend": 141645605, "cdsstart": 141542142, "chr": "8", "position": [[141530254, 141542251], [141542514, 141542714], [141549418, 141549553], [141551262, 141551457], [141554311, 141554402], [141557566, 141557726], [141559212, 141559397], [141561401, 141561535], [141565994, 141566117], [141566265, 141566385], [141567187, 141567335], [141568583, 141568671], [141569493, 141569628], [141570472, 141570609], [141572551, 141572733], [141582910, 141583031], [141595217, 141595410], [141645583, 141645732]], "strand": -1, "transcript": "NM_001164623", "txend": 141645732, "txstart": 141530254}, {"cdsend": 141645605, "cdsstart": 141542142, "chr": "8", "position": [[141530254, 141542251], [141542514, 141542714], [141545566, 141545668], [141549418, 141549553], [141551262, 141551457], [141554311, 141554402], [141557566, 141557726], [141559212, 141559397], [141561401, 141561535], [141565994, 141566117], [141566265, 141566385], [141567187, 141567335], [141568583, 141568671], [141569493, 141569628], [141570472, 141570609], [141572551, 141572733], [141582910, 141583031], [141595217, 141595410], [141645583, 141645732]], "strand": -1, "transcript": "NM_012154", "txend": 141645732, "txstart": 141530254}], "generif": [{"pubmed": 15284456, "text": "responsible for messenger RNA cleavage activity; evidence supports a model in which Argonaute contributes \"Slicer\" activity to RISC, providing the catalytic engine for RNAi"}, {"pubmed": 15800637, "text": "Argonaute proteins catalyze mRNA cleavage within RNA-Induced Silencing Complex"}, {"pubmed": 15908945, "text": "Argonaute 2, a key component of RISC, is not randomly distributed but concentrates in mRNA decay centres that are known as cytoplasmic bodies."}, {"pubmed": 16301602, "text": "Activity of siRNA duplexes containing full 2'-OMe substitutions in the sense strand is mediated by the RNA-induced silencing complex and that strand-specific loading to hAgo2 may be modulated through selective incorporation of these modifications."}, {"pubmed": 16357216, "text": "miRNA loading complex (miRLC) is formed by Ago2 and Dicer prior to their encounter with pre-miRNA."}, {"pubmed": 16611939, "text": "Here, we show that the human slicer Argonaute2 (HsAgo2), but not HsAgo1, functions in RNAi in the early divergent protozoan Trypanosoma brucei, thus mimicking the situation in mammalian cells"}, {"pubmed": 16936728, "text": "AGO1 and AGO2 associate with promoter DNA in cells treated with antigene RNAs (agRNAs), and inhibiting expression of AGO1 or AGO2 reverses transcriptional and post-transcriptional silencing."}, {"pubmed": 17116888, "text": "give a quantitative account of the Argonaute protein localization and dynamics in living cells in different cellular states"}, {"pubmed": 17382880, "text": "A crosslinking-coupled affinity purification method was used to isolate TNF-alpha AU-rich element-associated proteins: two microRNP-related proteins, FXR1 and AGO2 were found that associate during translation activation."}, {"pubmed": 17524464, "text": "Ago2 represses the initiation of mRNA translation by binding to the m(7)G cap of mRNA targets, thus likely precluding the recruitment of eIF4E"}, {"pubmed": 17531811, "text": "The action of RNA-induced silencing complex (RISC) requires the endonucleolytic slicer activity of Argonaute2 (Ago2)"}, {"pubmed": 17881374, "text": "Local widening of the duplex formed by the siRNA guide strand and the targeted region of mRNA is a possible reason for the intolerance of human Ago2, the RISC endonuclease, toward internal mismatch pairs involving native or chemically modified RNA."}, {"pubmed": 17891150, "text": "Results describe a repetitive motif within Tas3, termed the 'Argonaute hook', that is conserved from yeast to humans and binds Ago1 and 2 through their PIWI domains in vitro and in vivo."}, {"pubmed": 17932509, "text": "Data show that Argonaute1 and 2 reside in three complexes with distinct Dicer and RNA-induced silencing complex activities, and that the putative RNA-binding protein RBM4 is required for microRNA-guided gene regulation."}, {"pubmed": 18178619, "text": "Ago2, Dicer, and TRBP comprise the RISC-loading complex (RLC) and assembles spontaneously in vitro from purified components"}, {"pubmed": 18222171, "text": "These present data demonstrate that siAgo2 inhibited indispensable events of angiogenesis in vitro."}, {"pubmed": 18476811, "text": "The results suggest a potential regulatory mechanism for RNA silencing acting through Ago2 serine-387 phosphorylation mediated by the p38 MAPK pathway."}, {"pubmed": 18591665, "text": "Ectopic expression of the Argonaute-2 (Ago2, eIF2C2) dramatically enhances RNA interference specifically for mRNA targets with perfectly matched binding sites."}, {"pubmed": 18690212, "text": "findings identify hydroxylation as a post-translational modification important for Ago2 stability and effective RNA interference"}, {"pubmed": 18771919, "text": "The specificity of RNA interference depends on the concentration of Ago1, Ago3, and Ago4 relative to Ago2."}, {"pubmed": 18787018, "text": "Ago2 is regulated at both the transcriptional and posttranslational level, and Ago2 and enhanced micro-RNA activity is seen in the tumorigenic progression of breast cancer cell lines."}, {"pubmed": 18946079, "text": "Data show that siRNA transfection induces up-regulated expression of both GW182, a key P-body component, and Ago2, indicating that P-body localization and interaction with GW182 and Ago2 are important in siRNA-mediated RNAi."}, {"pubmed": 18981691, "text": "plays a roll in processes of tumor angiogenesis."}, {"pubmed": 19047128, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19061863, "text": "Mutant Ago2 protein containing 6 point mutations (G32W, F128L, R196Q, P458S, T741A, S752G) failed to accumulate in P-bodies."}, {"pubmed": 19064005, "text": "Data report that stable, long-term overexpression of Argonaute2, an Argonaute isoform, induces the production of a number of microRNAs, such as the let-7 family of microRNAs, in 293T cells."}, {"pubmed": 19138993, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19159466, "text": "Mapping of the MC sequence to the mid domain structure reveals Ago2 aromatics that are incompatible with eIF4E-like mRNA cap-binding, yet display some limited local structure similarities that cause the chance sequence match to eIF4E"}, {"pubmed": 19167051, "text": "Study demonstrates that Imp8 is required for the recruitment of Ago protein complexes to a large set of Ago2-associated target mRNAs, allowing for efficient and specific gene silencing."}, {"pubmed": 19324964, "text": "Tethering the C-terminal half of Ago2 to the 3'-UTR of reporter mRNA recapitulated translational repression comparable to that of tethered Ago2, and this repression was greatly impaired upon GW182 knockdown."}, {"pubmed": 19393748, "text": "EIF2C2 protein shows an opposite trend, with an expression in N-type cells that is lower than in I-type cells"}, {"pubmed": 19458189, "text": "Hsp90 is a critical modulator of Argonaute function."}, {"pubmed": 19508234, "text": "The interaction of Argonaute2 with the 5' uracil base plays a critical role in the recruitment of mRNA."}, {"pubmed": 19536157, "text": "High-throughput sequencing of Ago bound RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) identifies functional protein-RNA interaction sites in brain; validated miR-124 sites are also identified in HeLa cells."}, {"pubmed": 19625255, "text": "Ago2 immunoprecipitated from HeLa cells contained the double strand RNA-binding protein human immunodeficiency virus, type 1, trans-activating response RNA-binding protein"}, {"pubmed": 19723326, "text": "Data show that Ago1 and Ago2 (which encode argonautes, the key proteins forming the RNA-induced silencing complex (RISC)) had significantly higher expression levels in ER- than in ER+ breast cancer."}, {"pubmed": 19784364, "text": "Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors"}, {"pubmed": 19801630, "text": "Data show that RBM4 interacts directly with Ago2 during muscle cell differentiation and may recruit Ago2 to suppress translation of target mRNAs."}, {"pubmed": 19820710, "text": "The RLC Dicer's N-terminal DExH/D domain, located in a short 'base branch', interacts with TRBP, whereas its C-terminal catalytic domains in the main body are proximal to AGO2."}, {"pubmed": 19851984, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19946268, "text": "The authors demonstrate that AGO1 uses only miRNA duplexes when assembling translational repression-competent complexes, whereas AGO2 can use both miRNA and siRNA duplexes."}, {"pubmed": 20146808, "text": "EIF2C2-4 and PIWIL4 appear increased in advanced tumors with distant metastasis, suggesting they may promote tumor invasion"}, {"pubmed": 20197313, "text": "Data show that fibroblast growth factor-2 is regulated by an endogenous antisense RNA and by argonaute-2."}, {"pubmed": 20198652, "text": "data indicate that frameshift mutations in AGO2 and TNRC6A and their losses of expression are common in GCs and CRCs with MSI-H, and suggest that these alterations may contribute to the cancer development by deregulating miRNA regulation."}, {"pubmed": 20211803, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20237157, "text": "Data suggests that HSP90 protein chaperones Argonautes before binding RNA and may facilitate efficient loading of small RNA."}, {"pubmed": 20385818, "text": "Silencing of AGO2 dramatically decreased viability in multiple myeloma cell lines."}, {"pubmed": 20395958, "text": "Human Argonaute 2 targets cap-binding protein80/20-bound mRNAs and exon junction complex-bound mRNAs and inhibits nonsense-mediated mRNA decay which is restricted tightly to CBP80/20-bound mRNAs."}, {"pubmed": 20402672, "text": "over-expression of Ago2 and TNRC6A may be related to miRNA functions and might play a role in tumorigenesis of prostate carcinomas and esophageal squamous cell carcinomas."}, {"pubmed": 20505670, "text": "crystal structure of a MID domain from a eukaryotic AGO protein, human AGO2"}, {"pubmed": 20699384, "text": "Dicer knockout cells can generate mature miR-451 but not other miRNAs, whereas Ago2 knockout cells reconstituted with wild-type Ago2, but not Slicer-deficient Ago2, can process miR-451."}, {"pubmed": 20721975, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20924207, "text": "EIF2C2 is amplified and overexpressed in HNSCC cell lines and primary tumors and functionally significant in cell lines."}, {"pubmed": 21071408, "text": "The highly conserved tyrosine Y529, located in the small RNA 5'-end-binding pocket of Ago proteins such as Ago2 can be phosphorylated."}, {"pubmed": 21148147, "text": "This study strongly suggests that various kinds of cell stress are related to translocation of hAgo2 protein to endogenous stress granules."}, {"pubmed": 21177824, "text": "Ago2 was necessary for efficient miR-122 enhancement of hepatitis C virus RNA accumulation and translation."}, {"pubmed": 21241449, "text": "Data show that Argonaute 2 expression is critical for stem cells to escape senescence by downregulating miR10b and miR23b, and that selenoprotein N1 is also involved in ATSC survival and self-renewal through ROS-mediated p38 MAPK inactivation."}, {"pubmed": 21383194, "text": "Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma."}, {"pubmed": 21423624, "text": "Many mRNAs derived from genes containing long interspersed nuclear element -1 are elevated in Argonaute 2 (AGO2 or EIF2C2)-depleted cells."}, {"pubmed": 21535412, "text": "Knock-down of argonaute 2 (AGO2) induces apoptosis in myeloid leukaemia cells."}, {"pubmed": 21552258, "text": "C3PO endonuclease is an asymmetric octamer barrel consisting of six translin and two TRAX subunits which activates RISC by degrading the Ago2-nicked passenger strand of siRNA."}, {"pubmed": 21634124, "text": "reliable predictions of miRNA affinity to Ago2 AND Ago3 proteins were made."}, {"pubmed": 21769619, "text": "Our results suggest that Drosha, Dicer, and Ago2 are possibly implicated in colorectal carcinoma pathobiology"}, {"pubmed": 21840310, "text": "Study reveals that Ago2, but not Ago2F2V2, inhibits the binding of CBP80/20 to cap structure."}, {"pubmed": 21846468, "text": "Data show that Ago1, but not Ago2, overexpression in neuroblastoma cells causes slowing of the cell cycle, decreased cellular motility, and a stronger apoptotic response to UV."}, {"pubmed": 21868483, "text": "reveal that replication of hepatitis C virus (HCV) RNA depends on recruitment of Ago2 and miRNA-122 to lipid droplets, while suppression of HCV RNA by siRNA and Ago2 involves interaction with P-bodies"}, {"pubmed": 21951848, "text": "hAgo2 is recruited to stress granules as a consequence of its interaction with miRNAs."}, {"pubmed": 21964070, "text": "miR-671 directs cleavage of a circular antisense transcript of the Cerebellar Degeneration-Related protein 1 (CDR1) locus in an Ago2-slicer-dependent manner."}, {"pubmed": 21969601, "text": "Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2"}, {"pubmed": 22014067, "text": "the nuclear Ago2 regulation of the K+ channel or stemness-related gene expression plays a critical role in adult stem cell self-renewal and differentiation."}, {"pubmed": 22025453, "text": "DGCR8, AGO1, AGO2, PACT, and TARBP1 expression levels were significantly higher in the epithelial skin cancer groups than the healthy controls (P > 0.05)."}, {"pubmed": 22055194, "text": "Autoantigen La promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RNA-induced silencing complex catalysis."}, {"pubmed": 22163034, "text": "AGO2, PACT and TRBP are required for the efficient functioning of Dicer in cells"}, {"pubmed": 22215596, "text": "miR-122 binds hepatitis c viral RNA in association with Ago2 and that this slows decay of the viral genome in infected cells."}, {"pubmed": 22233755, "text": "Here the authors identified the N domain of human AGO2 as the initiator of duplex unwinding during RISC assembly."}, {"pubmed": 22366686, "text": "Data show that expression of RB1 repressed both the wild-type and let-7-mutated promoter."}, {"pubmed": 22394132, "text": "results provide novel evidence that Ago2 are probably involved in the pathobiology of human smooth muscle neoplasms"}, {"pubmed": 22474261, "text": "Ago3 is able to load microRNAs efficiently in the absence of Ago1 and Ago2, despite a significant loss of global microRNA expression"}, {"pubmed": 22539551, "text": "2.3 angstrom resolution crystal structure of Ago2 reveals a bilobed molecule with a central cleft for binding guide and target RNAs; nucleotides 2 to 6 of a heterogeneous mixture of guide RNAs are positioned in an A-form conformation for base pairing with target messenger RNAs"}, {"pubmed": 22647351, "text": "Drosha, Dicer, Argonaute 1, and Argonaute 2 are differentially expressed at different metastatic sites in ovarian carcinoma compared with primary carcinomas."}, {"pubmed": 22682761, "text": "Study reports the structure of human Ago2 bound to a physiologically relevant microRNA, microRNA-20a, at 2.2 A resolution; the miRNA is anchored at both ends by the Mid and PAZ domains and makes several kinks and turns along the binding groove and miRNA binding confers remarkable stability on hAgo2."}, {"pubmed": 22791714, "text": "APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10"}, {"pubmed": 22858679, "text": "Study observed a dramatic difference in AGO1 and AGO2 associated miRNA profiles in blood plasma. The lack of correlation between AGO1 and AGO2 miRNA content in the plasma can be explained by the fact that many tissues contribute to the extracellular miRNA content."}, {"pubmed": 22961379, "text": "AGO1 and AGO2 proteins couple RNA polymerase II elongation to chromatin modification"}, {"pubmed": 23019594, "text": "Ago2 and Ago1 can slice, and thus functionally bind, preannealed siRNA-mRNA duplexes."}, {"pubmed": 23077538, "text": "The majority of the secreted miRNAs were located in cell-secreted microvesicles, and these microvesicles-encapsulated miRNAs were bound to AGO2 complexes at various degrees."}, {"pubmed": 23091627, "text": "These results suggest that AGO2 and HBV-specific miRNAs might play a role in the HBV life cycle."}, {"pubmed": 23143396, "text": "Data show that the miRNA-processing enzyme, DICER and the main miRNA effector, AGO2, are targeted for degradation as miRNA-free entities by the selective autophagy receptor NDP52."}, {"pubmed": 23201202, "text": "Overexpression of human Argonaute2 inhibits cell and tumor growth."}, {"pubmed": 23245472, "text": "findings show that Argonaute-2 (Ago2) is required for miR-122-dependent replication of Hepatitis C Virus, but dispensable for miR-122-independent replication, confirming Ago2's role in mediating the activity of miR-122"}, {"pubmed": 23258480, "text": "Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma."}, {"pubmed": 23289589, "text": "interactions between the 5' nucleotide binding domain of AGO2 and chemically modified nucleotide analogues are investigated"}, {"pubmed": 23411422, "text": "Abnormal expression of Argonaute2 (EIF2C2) may be correlated with colon tumorigenesis."}, {"pubmed": 23512276, "text": "Data suggest that short RNA (additional RNA), and miR-122 activates the endonuclease activity of Ago2, resulting in cleavage of the Hepatitis C virus (HCV) 5' UTR."}, {"pubmed": 23603119, "text": "Akt3 coimmunoprecipitates with Ago2."}, {"pubmed": 23636329, "text": "EGFR, which is the product of a well-characterized oncogene in human cancers, suppresses the maturation of specific tumour-suppressor-like miRNAs in response to hypoxic stress through phosphorylation of argonaute 2 (AGO2) at Tyr 393"}, {"pubmed": 23664376, "text": "Highly complementary target RNAs destabilize the complex and significantly accelerate release of the guide RNA from Ago2."}, {"pubmed": 23665583, "text": "Introducing AAs 1-64 & 137-160 of Ago2 into Ago3 are sufficient to turn Ago3 into a slicer enzyme."}, {"pubmed": 23696368, "text": "MiR-184 regulates the expression of AGO2."}, {"pubmed": 23696926, "text": "Aberrant expression of argonaute-1/-2 in human renal cell carcinoma is possibly involved with tumorigenesis and prognosis."}, {"pubmed": 23741051, "text": "FKBP4, p23, and Aha1 cooperatively regulate the progression of hAgo2 through the chaperone cycle."}, {"pubmed": 23748378, "text": "2 new N-terminal Ago2 motifs (AAs 44-48 & 134-166) are key for slicing activity. The data support a dual role of the Ago2 N domain in RISC activation and mRNA cleavage."}, {"pubmed": 23775134, "text": "Ago2 was different between HER-2 positive and HER-2 negative groups."}, {"pubmed": 23824327, "text": "a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response."}, {"pubmed": 23877830, "text": "On the basis of the human Ago2 PAZ models, the indicators of stronger binding as the total binding energy and the free energy were associated with better RNAi efficacy"}, {"pubmed": 24023945, "text": "HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference"}, {"pubmed": 24141778, "text": "RPL5 binds to the TRBP2 and Ago2 subunits of the RISC and mediates the binding to c-Myc 3'UTR."}, {"pubmed": 24209750, "text": "Data show that trimming of Ago2-cleaved precursor miRNAs is not essential for target silencing, indicating that RISC is functional with miRNAs longer than the mature length."}, {"pubmed": 24263100, "text": "Findings highlight Ago2 as a new factor in myeloid cell fate determination in acute myeloid leukemia cells."}, {"pubmed": 24361012, "text": "This study identifies the targeting of Ago2 by miR-184 as an essential component of the compensatory response to regulate proliferation according to insulin sensitivity."}, {"pubmed": 24574065, "text": "Low AGO2 expression is associated with invasive breast carcinoma."}, {"pubmed": 24662483, "text": "Guided by DNA double-strand breaks induced small RNAs Ago2 can promote Rad51 recruitment and/or retention at DNA double-strand breaks to facilitate repair by homologous recombination."}, {"pubmed": 24727796, "text": "Results show that FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain."}, {"pubmed": 24788663, "text": "nature of the interactions of the EIF2C2/Ago2 PAZ domain"}, {"pubmed": 24805183, "text": "Data show that downregulation of AGO2 represses invasion, migration and epithelial-mesenchymal transition in prostate cancer cells."}, {"pubmed": 24886719, "text": "Data show that argonaute 2 (AGO2) can drive neovessel formation in vitro and in vivo by dysregulating the expression of some angiogenic miRNAs."}, {"pubmed": 24935600, "text": "Both argonaute 2 mRNA and protein were upregulated in high-grade when compared to low-grade tumor tissues. Multivariate analysis revealed that argonaute 2 protein expression was independently associated with the overall survival."}, {"pubmed": 25036361, "text": "Sumoylation of Ago2 at Lys402 negatively regulates its stability."}, {"pubmed": 25072345, "text": "Ago2 overexpression increased the level of miR-16 in cell-secreted MVs, suggesting that Ago2 may facilitate the packaging of secreted miRNAs into MVs."}, {"pubmed": 25135428, "text": "High Ago2 expression levels were associated with prostate cancer."}, {"pubmed": 25175024, "text": "Phosphorylation of AGO2 at Tyr 393 inhibited loading with microRNAs (miRNAs) and thus miRNA-mediated gene silencing, which counteracted the function of H-RAS(V12)-induced oncogenic miRNAs."}, {"pubmed": 25359968, "text": "this study determined crystal structures of human Argonaute-2 (Ago2) bound to a defined guide RNA with and without target RNAs representing miRNA recognition sites."}, {"pubmed": 25464849, "text": "A dual function for MOV10 in regulating translation: it facilitates microRNA-mediated translation of some RNAs, but it also increases expression of other RNAs by preventing AGO2 function."}, {"pubmed": 25605800, "text": "findings indicate that in human cells AGO2 binds SWI/SNF and a novel class of sRNAs to establish nucleosome occupancy on target TSSs"}, {"pubmed": 25673011, "text": "SERPINE1 mRNA dissociates from the translational repressor proteins Ago2 and TIA-1 upon platelet activation"}, {"pubmed": 25680411, "text": "our results indicate that IRF7 promotes glioma cell invasion and both chemoresistance and radioresistance through AGO2 inhibition"}, {"pubmed": 25826416, "text": "It was demonstrated by deep sequencing that AGO2-processed AgoshRNAs produce RNA effector molecules with more discrete ends than the products of the regular shRNA design."}, {"pubmed": 25918241, "text": "AGO2 binding to tRNA genes has a novel and important regulatory role in human cells."}, {"pubmed": 25937637, "text": "Knockdown of Ago2 in Huh7 cells and SMMC-7721 cells substantially decreased VEGF expression, whereas the restoration of AGO2 reversed both VEGF expression and secretion."}, {"pubmed": 25970378, "text": "Human AGO2 interacts only with sRNAs (20-30 nt in length), and not with DNA fragments."}, {"pubmed": 26140593, "text": "Study used single-molecule Fluorescence Resonance Energy Transfer to directly visualize how human Argonaute-2 searches for and identifies target sites in RNAs complementary to its miRNA guide; study shows that miRNA targeting by human Ago2 is a highly dynamic process that has been optimized for fast and efficient target recognition."}, {"pubmed": 26188282, "text": "PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma."}, {"pubmed": 26188511, "text": "Ago2 can be SUMOylated in cells by both SUMO1 and SUMO2. SUMOylation occurs primarily at K402, and mutation of the SUMO consensus site surrounding this lysine reduces Ago2-mediated siRNA-induced silencing in a luciferase-based reporter assay."}, {"pubmed": 26227789, "text": "Results indicate the role of Drosha, Dicer and Ago2 proteins in the development of non-small cell lung carcinomas (NSCLC) and suggest that Dicer may be implicated in the progression of these tumors to advanced stages."}, {"pubmed": 26242502, "text": "Blocking AGO1, AGO2, or TRBP expression changes expression levels and nuclear distribution of RNAi factors Dicer, TNRC6A (GW182), and TRBP."}, {"pubmed": 26253535, "text": "a novel mechanism by which AUF1 binding and transfer of microRNA let-7 to AGO2 facilitates let-7-elicited gene silencing."}, {"pubmed": 26304123, "text": "mRNA Targeting to Endoplasmic Reticulum Precedes Ago Protein Interaction and MicroRNA (miRNA)-mediated Translation Repression"}, {"pubmed": 26359634, "text": "Human Argonaute2 (Ago2) possesses a solvated surface pocket that specifically binds adenine nucleobases in the 1 position (t1) of target RNAs."}, {"pubmed": 26443379, "text": "Targeting of Ago2 to P-bodies and stress granules is separable from its role in RNAi and likely requires dynamic phosphorylation of serine 798."}, {"pubmed": 26451954, "text": "HuR and Ago2 Bind the Internal Ribosome Entry Site of Enterovirus 71 and Promote Virus Translation and Replication"}, {"pubmed": 26475020, "text": "AGO2 suppression by miR-132 affects the steady state levels of miR-221 and miR-146a, two miRNAs involved in angiogenesis and inflammation, respectively."}, {"pubmed": 26507454, "text": "MiR-138 suppresses hTERT expression in an AGO2-dependent manner."}, {"pubmed": 26518874, "text": "GRSF1 participated in the regulation of AGO2 by miR-346, and the middle sequence of miR-346 was vital for the synergy effect of miR-346 and GRSF1."}, {"pubmed": 26545861, "text": "genetic polymorphism in AGO2 may be a risk factor for the advanced lymph node metastasis of NPC in Chinese populations, and AGO2 acts as an oncogene in the development of NPC."}, {"pubmed": 26592935, "text": "Authors found that target binding of core-RISC starts at the seed region of the guide RNA. After target binding, four distinct reactions followed: target cleavage, transient binding, stable binding, and Argonaute 2 unloading."}, {"pubmed": 26699195, "text": "the subcellular distribution of Ago2 occurs in a cell type- and tissue context-dependent manner and may correlate with its various functions in regulation of gene expression"}, {"pubmed": 26701625, "text": "TP53 regulates miRNA association with AGO2 to remodel the miRNA-mRNA interaction network"}, {"pubmed": 26809675, "text": "DIS3L2 interacts with Ago2 and governs target RNA-directed miRNA degradation."}, {"pubmed": 26854235, "text": "KRAS engages AGO2 to enhance cellular neoplastic transformation."}, {"pubmed": 27117408, "text": "overactivity of KRAS due to mutation inhibits localization of Ago2 to multivesicular endosomes (MVEs) and decreases Ago2 secretion in exosomes."}, {"pubmed": 27142104, "text": "These results support the notion that the cereblon binding partner AGO2 plays an important role in regulating MM cell growth and survival and AGO2 could be considered as a novel drug target for overcoming IMiD resistance in MM cells."}, {"pubmed": 27208409, "text": "data indicates that the aberrant expression of miR-15b contributes to abnormal placentation by targeting argonaute 2 messenger RNA"}, {"pubmed": 27288410, "text": "1174 regions within the 45S rRNA transcript that have the ability to form a perfect duplex with position 2-6 (seed sequence) of each microRNA expressed in HEK293T cells. Of these potential AGO2 binding sites, 479 occurred within experimentally verified AGO2-rRNA cross-linking sites. The ability of AGO2 to cross-link to rRNA was almost completely lost in a DICER knock-out cell line."}, {"pubmed": 27418678, "text": "deciphering Ago2:RNA interactions using crosslinking immunoprecipitation coupled with high-throughput sequencing (HITS-CLIP) to generate the first transcriptome-wide map of miR targeting events in human myocardium, detecting 4000 cardiac Ago2 binding sites across 2200 target transcripts"}, {"pubmed": 27478153, "text": "The miRNA biogenesis factors, DDX17 and KHSRP, regulate the protein level of Ago2 in human cells."}, {"pubmed": 27486976, "text": "Data show that neuropilin 1 (NRP1) binds extracellular AGO2 (carrying miRNA or not), and internalizes AGO2/miRNA complexes."}, {"pubmed": 27518285, "text": "Low AGO2 expression is associated with melanoma."}, {"pubmed": 27721445, "text": "extracellular vesicles are efficiently internalized by endothelial cells, where the miRNA-Argonaute 2 complexes modulate target gene expression and barrier properties."}, {"pubmed": 27924485, "text": "we describe these two methodologies that we recently used to select a specific compound able to interfere with the AGO2 functional activity and able to improve the retinoic acid-dependent myeloid differentiation of leukemic cells."}, {"pubmed": 27924486, "text": "Here, we describe the use of SPR techniques to study the interaction between Argonaute 2 and small molecular compounds selected by means of high-throughput docking screening."}, {"pubmed": 27924487, "text": "Since miRNAs' functions are executed exclusively by the Argonaute 2 protein, we therefore describe a protocol for the design of a novel miRNA inhibitor class: antagonists of the miRNA-Argonaute 2 protein complex, so-called anti-miR-AGOs, that not only block the crucial binding site of the target miRNA but also bind to the protein's active site."}, {"pubmed": 27924488, "text": "Using our recent work on human AGO2 as an example, we explain the rationale and the workflow of our method in details. This combined approach holds great promise to complement experiments in unraveling the mechanisms of molecular recognition between large, flexible, and complex biomolecules."}, {"pubmed": 27924489, "text": "Here, we present techniques to kinetically characterize recombinant Argonaute 2-mediated guide and target binding as well as target RNA slicing. We focus on fluorescence-based steady-state and in particular pre-steady-state techniques to unravel mechanistic details. Furthermore, we describe a cleavage assay to analyze Argonaute 2-mediated slicing using radioactively labeled target strands."}, {"pubmed": 28008821, "text": "this study analysed binding of miR-122/ Argonaute 2 complexes to two conserved binding sites in the 5' UTR of hepatitis C virus RNA."}, {"pubmed": 28075055, "text": "AGO2 immunoprecipitation revealed LATS1 as a novel proapoptotic target of miR-21 in T cells."}, {"pubmed": 28082397, "text": "This lack of 21-3U HCV host factor activity correlated with reduced recruitment of Ago2 to the HCV S1 site. Additional experiments demonstrated strong preference for guanosine at nt 22 of miR-122. Our findings reveal the importance of non-templated 3 miR-122 modifications to its HCV host factor activity, and identify unexpected differences in miRNA requirements for host gene suppression versus RNA virus replication."}, {"pubmed": 28114302, "text": "findings support a model in which an AGO2 phosphorylation cycle stimulated by target engagement regulates miRNA:target interactions to maintain the global efficiency of miRNA-mediated silencing"}, {"pubmed": 28334781, "text": "Depletion of AUF1 abolishes the global interaction of miRNAs and AGO2. Single-molecule analysis revealed that AUF1 slowed down assembly of AGO2-let-7b-mRNA complex unexpectedly. AUF1 is a decay-promoting factor influencing multiple steps in AGO2-miRNA-mediated mRNA decay."}, {"pubmed": 28388001, "text": "This study employed molecular dynamics simulation to investigate the dynamic properties of human Ago2-RNA-duplex system and Ago2-free system to provide further understanding of the molecular mechanism of Ago2-RNA recognition."}, {"pubmed": 28472401, "text": "WIG1 governs the miRNA-dependent and the miRNA-independent recruitment of AGO2 to lower the stability of and suppress the translation of ACOT7 mRNA."}, {"pubmed": 28645918, "text": "Altogether, these data suggest that the phosphorylation state of the serine/threonine cluster is important for Argonaute-mRNA interactions."}, {"pubmed": 28683311, "text": "Phosphorylation of AGO2 at Ser 387 by Akt3 induces LIMD1 binding, which in turn enables AGO2 to interact with TNRC6A and downstream effector DDX6."}, {"pubmed": 28831191, "text": "We found a much larger number of microparticles (MPs) results demonstrate that normal RBCs display an innate ability to resist infection by P. falciparum parasite by releasing Ago2-miRNA complexes via microparticles (MPs)into infected RBCs; data suggest that, through release of MPs, mature RBCs present an innate resistance to malaria infection"}, {"pubmed": 28839112, "text": "The adenovirus major late promoter produces a 31-nucleotide transcriptional start site small RNA (MLP-TSS-sRNA) that retains the 7-methylguanosine (m7G)-cap and is incorporated onto Ago2-containing RNA-induced silencing complexes (RISC) in human adenovirus-37 infected cells."}, {"pubmed": 28850112, "text": "Decreased argonaute 2 and dicer1 in peripheral blood mononuclear cells from War Veterans with post-traumatic stress disorder leads to diminished miRNA resulting in elevated inflammation."}, {"pubmed": 28954383, "text": "CASC7 expression was significantly decreased in colorectal cancer (CRC) tissues and CRC cell lines; CASC7 overexpression could inhibit cell viability, migration and invasion, and promote apoptosis in CRC cells"}, {"pubmed": 29017520, "text": "A dual role of the association between AGO2 and ERbeta in luminal-like breast cancer cells in the nucleus and the cytoplasm, for the regulation of gene expression at both the transcriptional and post-transcriptional level."}, {"pubmed": 29028450, "text": "Here we show that biotin-labelled miR-34a can be loaded to AGO2, and AGO2 immunoprecipitation can pulldown biotinylated miR-34a (Bio-miR pulldown). RNA-sequencing (RNA-seq) of the Bio-miR pulldown RNAs efficiently identified miR-34a mRNA targets, which could be verified with luciferase assays"}, {"pubmed": 29031931, "text": "AGO2-mediated cleavage of targets is more common than previously thought. This may explain the vital role of endonuclease activity in controlling miRNA-mediated gene regulation."}, {"pubmed": 29256262, "text": "the polymorphisms of the AGO1 and AGO2 genes, the expression levels of which correlated with the proportion of Th17 cells, were associated with the development and prognosis of Graves' disease."}, {"pubmed": 29444957, "text": "P38 activation repressed the cooperation of TTP with Ago2, thus ensuring that ARE-mRNA does not associate with processing bodies and remains stable."}, {"pubmed": 29573145, "text": "Downregulation of AGO2 in proliferating human diploid fibroblasts (HDFs) also correlated with a decrease in AGO2 mRNA modifications and steady-state levels."}, {"pubmed": 29748555, "text": "PTBP1 enhances miR-101-guided AGO2 interaction with MCL1, thereby regulating miR-101-induced apoptosis and clonogenic cell survival inhibition in cells."}, {"pubmed": 30089251, "text": "Accumulation of AGO2, a key factor of the RNA-induced silencing complex that executes microRNA functions, results in global alterations of microRNA levels and activity."}, {"pubmed": 30239883, "text": "we built a computational model that evaluates the importance of base pairing beyond the seed in AGO2-mediated repression. This model suggests that when the seed region is perfectly base paired with the target, then the bps in module-B (nts 12-14) play a decisive role."}, {"pubmed": 30305728, "text": "Our finding reveals a novel function of AGO2 acetylation in increasing oncogenic miR-19b biogenesis and suggests that modulation of AGO2 acetylation has potential clinical implications."}, {"pubmed": 30306823, "text": "We observed that the designed ss-miR-216b mimics engaged AGO2 to promote the silencing of KRAS. We also tested a new delivery strategy based on the use of palmityl-oleyl-phosphatidylcholine (POPC) liposomes functionalized with ss-miR-216b conjugated with two palmityl chains and a lipid-modified cell penetrating peptide . These versatile nanoparticles suppressed oncogenic KRAS in pancreatic ductal adenocarcinoma cells"}, {"pubmed": 30333515, "text": "A transcriptome-wide approach was used to determine the binding profiles and inter-dependencies of Argonaute2 (AGO2), Pumilio (PUM1 and PUM2) sites on mRNA 3' untranslated regions (3'UTRs)."}, {"pubmed": 30341421, "text": "The oncogenic circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes."}, {"pubmed": 30476917, "text": "IFN-gamma and TNF induce a stable cell cycle arrest of cancer cells that is accompanied by a fast nuclear Ago2 translocation and repression of Ago2-regulated cell cycle control genes. As Ago2 downregulation impairs cytokine-induced growth regulation, Ago2 may contribute to tissue homeostasis in human cancers."}, {"pubmed": 30567739, "text": "results reveal a critical mechanism by which Ser-195 phosphorylation in Rbm38 increases p63 expression by attenuating the association of Rbm38 with the Ago2-miR203 complex."}, {"pubmed": 30621629, "text": "The results revealed that there were 243 miRNAs and 265 miRNAs in the Ago2 complexes of nucleus and cytoplasm, respectively. The majority of mature miRNAs existed in cytoplasm. The analysis of miRNA targetome from the Ago2 complexes indicated that a lot of mRNAs with high expression level existed in nucleus."}, {"pubmed": 30622242, "text": "These results highlight that the Ago2 protein in cancer cells strictly dictates miR-145-5p tumor suppressor activity."}, {"pubmed": 30661904, "text": "all research findings suggested that CASC7 inhibited the progression of glioma via regulating Wnt/beta-catenin signaling pathway"}, {"pubmed": 30941417, "text": "hAgo2:miR-122 complexes alter the structure of the viral 5' terminus and promote formation of the hepatitis C virus internal ribosomal entry site"}, {"pubmed": 31112282, "text": "L1-5'UTR harbors both sense and antisense promoter activity and a dsRNA-mediated regulation is responsible for L1-5'UTR regulation. Agos proteins and L1-ORF1p were engaged in this process."}, {"pubmed": 31268608, "text": "The observation that crystallized Ago2 in a conformation that avoided central pairing, despite the presence of complementarity to that region, not only demonstrates that Ago2 can make supplementary interactions without central pairing, but also suggests that this may be an energetically favored route for establishing miRNA-target pairing beyond the seed."}, {"pubmed": 31324173, "text": "Reduced expression of Ago2 is associated with poor patient survival, and Ago2 may be useful as part of future prognostic gene panels or stratification signatures."}, {"pubmed": 31424151, "text": "Biphasic regulation of RNA interference during rotavirus infection by modulation of Argonaute2."}, {"pubmed": 31551491, "text": "No evidence for viral small RNA production and antiviral function of Argonaute 2 in human cells."}, {"pubmed": 31655860, "text": "The RNA-RNA base pairing potential of human Dicer and Ago2 proteins."}, {"pubmed": 31666609, "text": "Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss."}, {"pubmed": 31724726, "text": "The association of AGO1 (rs595961G>A, rs636832A>G) and AGO2 (rs11996715C>A, rs2292779C>G, rs4961280C>A) polymorphisms and risk of recurrent implantation failure."}, {"pubmed": 31941754, "text": "AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma."}, {"pubmed": 32164444, "text": "AGO2 and its partners: a silencing complex, a chromatin modulator, and new features."}, {"pubmed": 32175808, "text": "Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells."}, {"pubmed": 32191872, "text": "Ago2-Dependent Processing Allows miR-451 to Evade the Global MicroRNA Turnover Elicited during Erythropoiesis."}, {"pubmed": 32420319, "text": "Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma."}, {"pubmed": 32488030, "text": "AGO-bound mature miRNAs are oligouridylated by TUTs and subsequently degraded by DIS3L2."}, {"pubmed": 32499547, "text": "An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development."}, {"pubmed": 32626930, "text": "The long noncoding RNA CASC7 inhibits growth and invasion of nonsmall cell lung cancer cells through phosphatase and tensin homolog upregulation via sequestration of miR92a."}, {"pubmed": 32659369, "text": "The cooperative complex of Argonaute-2 and microRNA-146a regulates hepatitis B virus replication through flap endonuclease 1."}, {"pubmed": 32661421, "text": "mRNA structural dynamics shape Argonaute-target interactions."}, {"pubmed": 32696070, "text": "Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts."}, {"pubmed": 32717920, "text": "Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID."}, {"pubmed": 32778571, "text": "MicroRNA-Independent Modulation of DICER1 Expression by hAgo2."}, {"pubmed": 32800344, "text": "Sequestosome 1 (p62) accumulation in breast cancer cells suppresses progesterone receptor expression via argonaute 2."}, {"pubmed": 32929008, "text": "Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides."}, {"pubmed": 33122430, "text": "Human Argonaute2 and Argonaute3 are catalytically activated by different lengths of guide RNA."}, {"pubmed": 33199684, "text": "Germline AGO2 mutations impair RNA interference and human neurological development."}, {"pubmed": 33604619, "text": "DDX21 interacts with nuclear AGO2 and regulates the alternative splicing of SMN2."}, {"pubmed": 33685914, "text": "GW182 Proteins Restrict Extracellular Vesicle-Mediated Export of MicroRNAs in Mammalian Cancer Cells."}, {"pubmed": 33838501, "text": "The miRISC component AGO2 has multiple binding sites for Nup358 SUMO-interacting motif."}, {"pubmed": 34039517, "text": "Phosphorylation of Ago2 is required for its role in DNA double-strand break repair."}, {"pubmed": 34108230, "text": "Argonaute binding within human nuclear RNA and its impact on alternative splicing."}, {"pubmed": 34117353, "text": "AGO2 localizes to cytokinetic protrusions in a p38-dependent manner and is needed for accurate cell division."}, {"pubmed": 34518544, "text": "Hypoxia regulates overall mRNA homeostasis by inducing Met(1)-linked linear ubiquitination of AGO2 in cancer cells."}, {"pubmed": 34672687, "text": "AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes."}, {"pubmed": 34685771, "text": "Unexpected Implication of SRP and AGO2 in Parkinson's Disease: Involvement in Alpha-Synuclein Biogenesis."}, {"pubmed": 34821414, "text": "YTHDF1 promotes mRNA degradation via YTHDF1-AGO2 interaction and phase separation."}, {"pubmed": 34848812, "text": "Critical role of backbone coordination in the mRNA recognition by RNA induced silencing complex."}, {"pubmed": 35459267, "text": "p63, a key regulator of Ago2, links to the microRNA-144 cluster."}, {"pubmed": 35638597, "text": "Target binding triggers hierarchical phosphorylation of human Argonaute-2 to promote target release."}, {"pubmed": 35780145, "text": "Single-molecule FRET uncovers hidden conformations and dynamics of human Argonaute 2."}, {"pubmed": 36050755, "text": "NF90 interacts with components of RISC and modulates association of Ago2 with mRNA."}, {"pubmed": 36142498, "text": "Association of Polymorphic Variants in Argonaute Genes with Depression Risk in a Polish Population."}, {"pubmed": 36424716, "text": "Upregulation of miR-184 and miR-19a-3p induces endothelial dysfunction by targeting AGO2 in Kawasaki disease."}, {"pubmed": 36881338, "text": "CircAGO2 promotes colorectal cancer progression by inhibiting heat shock protein family B (small) member 8 via miR-1-3p/retinoblastoma binding protein 4 axis."}, {"pubmed": 36901936, "text": "miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2."}, {"pubmed": 37221016, "text": "The CHARGE syndrome-associated protein FAM172A controls AGO2 nuclear import."}, {"pubmed": 37271493, "text": "The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2."}, {"pubmed": 37330182, "text": "Long non-coding RNA PFI inhibits apoptosis of alveolar epithelial cells to alleviate lung injury via miR-328-3p/Creb1 axis."}, {"pubmed": 37735632, "text": "Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma."}, {"pubmed": 37810197, "text": "hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492."}, {"pubmed": 37819702, "text": "Actin-dependent recruitment of AGO2 to the zonula adherens."}, {"pubmed": 38109320, "text": "Nuclear localization of Argonaute 2 is affected by cell density and may relieve repression by microRNAs."}, {"pubmed": 38215077, "text": "AGO2-RIP-Seq reveals miR-34/miR-449 cluster targetome in sinonasal cancers."}, {"pubmed": 38351659, "text": "Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC."}, {"pubmed": 38649663, "text": "Ago2/CAV1 interaction potentiates metastasis via controlling Ago2 localization and miRNA action."}, {"pubmed": 39097877, "text": "CRISPR-Cas9 Mediated AGO2 Knockout inhibits tumorigenesis in human colorectal cancer cells."}], "genomic_pos": {"chr": "8", "end": 140635633, "ensemblgene": "ENSG00000123908", "start": 140520156, "strand": -1}, "genomic_pos_hg19": {"chr": "8", "end": 141645718, "start": 141541264, "strand": -1}, "go": {"BP": [{"evidence": "NAS", "gocategory": "BP", "id": "GO:0006412", "pubmed": 10534406, "qualifier": "involved_in", "term": "translation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006413", "qualifier": "involved_in", "term": "translational initiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009791", "qualifier": "involved_in", "term": "post-embryonic development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010501", "pubmed": 19966796, "qualifier": "involved_in", "term": "RNA secondary structure unwinding"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010501", "pubmed": 22795694, "qualifier": "involved_in", "term": "RNA secondary structure unwinding"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010586", "qualifier": "involved_in", "term": "miRNA metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030422", "pubmed": 23661684, "qualifier": "involved_in", "term": "siRNA processing"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0031047", "qualifier": "involved_in", "term": "regulatory ncRNA-mediated gene silencing"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0031054", "qualifier": "involved_in", "term": "pre-miRNA processing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0031054", "pubmed": [16424907, 17671087, 18178619, 19966796, 23661684], "qualifier": "involved_in", "term": "pre-miRNA processing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033962", "pubmed": 31400113, "qualifier": "involved_in", "term": "P-body assembly"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035194", "qualifier": "involved_in", "term": "regulatory ncRNA-mediated post-transcriptional gene silencing"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0035194", "qualifier": "involved_in", "term": "regulatory ncRNA-mediated post-transcriptional gene silencing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035196", "pubmed": [19966796, 23661684], "qualifier": "involved_in", "term": "miRNA processing"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035278", "pubmed": [17671087, 19801630, 23409027], "qualifier": "involved_in", "term": "miRNA-mediated gene silencing by inhibition of translation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035278", "pubmed": 18771919, "qualifier": "involved_in", "term": "miRNA-mediated gene silencing by inhibition of translation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035279", "pubmed": [15260970, 17524464], "qualifier": "involved_in", "term": "miRNA-mediated gene silencing by mRNA destabilization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035279", "pubmed": 18771919, "qualifier": "involved_in", "term": "miRNA-mediated gene silencing by mRNA destabilization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0042985", "qualifier": "involved_in", "term": "negative regulation of amyloid precursor protein biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045727", "pubmed": 17382880, "qualifier": "involved_in", "term": "positive regulation of translation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045766", "pubmed": 27208409, "qualifier": "involved_in", "term": "positive regulation of angiogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045944", "pubmed": 25336585, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045947", "pubmed": [17524464, 19801630], "qualifier": "involved_in", "term": "negative regulation of translational initiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060213", "qualifier": "involved_in", "term": "positive regulation of nuclear-transcribed mRNA poly(A) tail shortening"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070922", "pubmed": [19701182, 19966796, 23661684], "qualifier": "involved_in", "term": "RISC complex assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090128", "pubmed": 29735530, "qualifier": "involved_in", "term": "regulation of synapse maturation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090128", "pubmed": 29735530, "qualifier": "involved_in", "term": "regulation of synapse maturation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0090625", "pubmed": 15260970, "qualifier": "involved_in", "term": "siRNA-mediated gene silencing by mRNA destabilization"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090625", "pubmed": 22795694, "qualifier": "involved_in", "term": "siRNA-mediated gene silencing by mRNA destabilization"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1900153", "qualifier": "involved_in", "term": "positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1901165", "pubmed": 27208409, "qualifier": "involved_in", "term": "positive regulation of trophoblast cell migration"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000932", "pubmed": [20616046, 22915799, 23125361], "qualifier": "located_in", "term": "P-body"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005634", "pubmed": 25336585, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 23985560, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": [15260970, 17932509, 20014101], "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 19946888, "qualifier": "located_in", "term": "membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0016442", "qualifier": "part_of", "term": "RISC complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016442", "pubmed": [15260970, 17531811, 17671087, 17932509, 19701182, 19966796, 20616046], "qualifier": "part_of", "term": "RISC complex"}, {"evidence": "IGI", "gocategory": "CC", "id": "GO:0016442", "pubmed": [31012336, 31507089], "qualifier": "part_of", "term": "RISC complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0016442", "pubmed": 19826008, "qualifier": "part_of", "term": "RISC complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030425", "qualifier": "located_in", "term": "dendrite"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0036464", "qualifier": "is_active_in", "term": "cytoplasmic ribonucleoprotein granule"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0036464", "qualifier": "located_in", "term": "cytoplasmic ribonucleoprotein granule"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 28159509, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0070578", "pubmed": [15973356, 17531811, 18178619, 19820710, 19966796, 23661684], "qualifier": "part_of", "term": "RISC-loading complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0070578", "pubmed": 23661684, "qualifier": "part_of", "term": "RISC-loading complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0098794", "pubmed": 29735530, "qualifier": "is_active_in", "term": "postsynapse"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0098794", "pubmed": 29735530, "qualifier": "is_active_in", "term": "postsynapse"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0098978", "pubmed": 29735530, "qualifier": "is_active_in", "term": "glutamatergic synapse"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0098978", "pubmed": 29735530, "qualifier": "is_active_in", "term": "glutamatergic synapse"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0000340", "pubmed": 17524464, "qualifier": "enables", "term": "RNA 7-methylguanosine cap binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000993", "pubmed": 25336585, "qualifier": "enables", "term": "RNA polymerase II complex binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0001046", "pubmed": 25336585, "qualifier": "enables", "term": "core promoter sequence-specific DNA binding"}, {"category": "MF", "evidence": "HDA", "id": "GO:0003723", "pubmed": [22658674, 22681889], "qualifier": "enables", "term": "RNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003725", "pubmed": 19966796, "qualifier": "enables", "term": "double-stranded RNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003727", "qualifier": "enables", "term": "single-stranded RNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003727", "pubmed": 19966796, "qualifier": "enables", "term": "single-stranded RNA binding"}, {"category": "MF", "evidence": "NAS", "id": "GO:0003743", "pubmed": 10534406, "qualifier": "enables", "term": "translation initiation factor activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004521", "qualifier": "enables", "term": "RNA endonuclease activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004521", "pubmed": 18178619, "qualifier": "enables", "term": "RNA endonuclease activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004521", "qualifier": "enables", "term": "RNA endonuclease activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [14749716, 15766526, 16289642, 16424907, 16699599, 16756390, 17400507, 17507929, 17531811, 17891150, 17932509, 18178619, 19167051, 19324964, 19383768, 19716330, 19801630, 19820710, 19838187, 19955415, 20616046, 20671708, 21525958, 21840310, 21858095, 21903422, 21981923, 22366686, 22484317, 22915799, 23085987, 23090477, 23125361, 23361462, 23409027, 23622242, 23636329, 23661684, 23741051, 24043833, 24550003, 24726324, 24862572, 24981741, 25336585, 25446899, 25697406, 26009488, 26496610, 27157137, 28546213, 28683311, 28877994, 29395067, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0035197", "pubmed": [15973356, 19701182], "qualifier": "contributes_to", "term": "siRNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0035197", "pubmed": 17495927, "qualifier": "enables", "term": "siRNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0035198", "qualifier": "enables", "term": "miRNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0035198", "pubmed": [15260970, 19966796], "qualifier": "enables", "term": "miRNA binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0035198", "pubmed": [31012336, 31507089], "qualifier": "enables", "term": "miRNA binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0035198", "pubmed": 19820710, "qualifier": "enables", "term": "miRNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0035925", "pubmed": 17382880, "qualifier": "enables", "term": "mRNA 3'-UTR AU-rich region binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0070551", "pubmed": [15260970, 17524464], "qualifier": "enables", "term": "endoribonuclease activity, cleaving siRNA-paired mRNA"}, {"category": "MF", "evidence": "IDA", "id": "GO:0090624", "pubmed": 15260970, "qualifier": "enables", "term": "endoribonuclease activity, cleaving miRNA-paired mRNA"}, {"category": "MF", "evidence": "IMP", "id": "GO:0090624", "pubmed": 22795694, "qualifier": "enables", "term": "endoribonuclease activity, cleaving miRNA-paired mRNA"}, {"category": "MF", "evidence": "IDA", "id": "GO:0098808", "pubmed": 17524464, "qualifier": "enables", "term": "mRNA cap binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0098808", "pubmed": 23409027, "qualifier": "enables", "term": "mRNA cap binding"}]}, "homologene": {"genes": [[3702, 817334], [6239, 173468], [6239, 181504], [7165, 1280922], [7227, 36544], [7955, 570630], [8364, 448205], [9031, 100858102], [9544, 711873], [9598, 737376], [9606, 27161], [9615, 475107], [9913, 404130], [10090, 239528], [10116, 59117]], "id": 81825}, "interpro": [{"desc": "PAZ domain superfamily", "id": "IPR036085", "short_desc": "PAZ_dom_sf"}, {"desc": "PAZ domain", "id": "IPR003100", "short_desc": "PAZ_dom"}, {"desc": "Piwi domain", "id": "IPR003165", "short_desc": "Piwi"}, {"desc": "Ribonuclease H-like superfamily", "id": "IPR012337", "short_desc": "RNaseH-like_sf"}, {"desc": "Argonaute, linker 1 domain", "id": "IPR014811", "short_desc": "ArgoL1"}, {"desc": "Protein argonaute-2", "id": "IPR028602", "short_desc": "AGO2"}, {"desc": "Argonaute linker 2 domain", "id": "IPR032472", "short_desc": "ArgoL2"}, {"desc": "Protein argonaute, Mid domain", "id": "IPR032473", "short_desc": "Argonaute_Mid_dom"}, {"desc": "Protein argonaute, N-terminal", "id": "IPR032474", "short_desc": "Argonaute_N"}, {"desc": "Ribonuclease H superfamily", "id": "IPR036397", "short_desc": "RNaseH_sf"}, {"desc": "Argonaute-like, PIWI domain", "id": "IPR045246", "short_desc": "Piwi_ago-like"}], "ipi": ["IPI00745433", "IPI00929290", "IPI00973784", "IPI01014654"], "map_location": "8q24.3", "name": "argonaute RISC catalytic component 2", "other_names": ["PAZ Piwi domain protein", "argonaute 2, RISC catalytic component", "cancer susceptibility candidate 7 (non-protein coding)", "eukaryotic translation initiation factor 2C, 2", "long intergenic non-protein coding RNA 980", "protein argonaute-2", "protein slicer"], "pantherdb": {"HGNC": "3263", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2446632", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 10090, "uniprot_kb": "Q8CJG0"}, {"RGD": "621255", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 10116, "uniprot_kb": "Q9QZ81"}, {"Ensembl": "ENSGALG00000040957", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 9031, "uniprot_kb": "A0A1D5NTU6"}, {"Ensembl": "ENSDARG00000061268", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 7955, "uniprot_kb": "E7EXY4"}, {"WormBase": "WBGene00019862", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q21691"}, {"WormBase": "WBGene00020707", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q9TXN7"}, {"WormBase": "WBGene00007624", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q09249"}, {"WormBase": "WBGene00011910", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "G5ED77"}, {"WormBase": "WBGene00006449", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "P34681"}, {"WormBase": "WBGene00007297", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q9XVF1"}, {"WormBase": "WBGene00017641", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "H2KZD5"}, {"WormBase": "WBGene00004323", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "G5EEH0"}, {"WormBase": "WBGene00019666", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "A0A0T7CIX3"}, {"WormBase": "WBGene00004094", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q9N585"}, {"WormBase": "WBGene00010263", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "O62275"}, {"WormBase": "WBGene00004093", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q86NJ8"}, {"WormBase": "WBGene00018921", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "A0A0U1RML5"}, {"WormBase": "WBGene00022877", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "D9N120"}, {"WormBase": "WBGene00011061", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q21770"}, {"WormBase": "WBGene00019971", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "O61931"}, {"WormBase": "WBGene00011945", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "Q9XVI3"}, {"WormBase": "WBGene00000106", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "O16720"}, {"WormBase": "WBGene00000105", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 6239, "uniprot_kb": "G5EES3"}, {"FlyBase": "FBgn0087035", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 7227, "uniprot_kb": "Q9VUQ5"}, {"FlyBase": "FBgn0262739", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 7227, "uniprot_kb": "Q32KD4"}, {"PomBase": "SPCC736.11", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 4896, "uniprot_kb": "O74957"}, {"TAIR": "2147072", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q3E984"}, {"TAIR": "2179008", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q84VQ0"}, {"TAIR": "2059258", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9ZVD5"}, {"TAIR": "2059370", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "O48771"}, {"TAIR": "2197550", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9SHF2"}, {"TAIR": "2197545", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9SHF3"}, {"TAIR": "2057851", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9SJK3"}, {"TAIR": "2170897", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9XGW1"}, {"TAIR": "2007111", "ortholog_type": "O", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "Q9C793"}, {"TAIR": "2007760", "ortholog_type": "LDO", "panther_family": "PTHR22891", "taxid": 3702, "uniprot_kb": "O04379"}], "uniprot_kb": "Q9UKV8"}, "pathway": {"reactome": [{"id": "R-HSA-1257604", "name": "PIP3 activates AKT signaling"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-1500931", "name": "Cell-Cell communication"}, {"id": "R-HSA-1500931", "name": "Cell-Cell communication"}, {"id": "R-HSA-157118", "name": "Signaling by NOTCH"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-1912408", "name": "Pre-NOTCH Transcription and Translation"}, {"id": "R-HSA-1912422", "name": "Pre-NOTCH Expression and Processing"}, {"id": "R-HSA-195721", "name": "Signaling by WNT"}, {"id": "R-HSA-203927", "name": "MicroRNA (miRNA) biogenesis"}, {"id": "R-HSA-211000", "name": "Gene Silencing by RNA"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-3700989", "name": "Transcriptional Regulation by TP53"}, {"id": "R-HSA-3858494", "name": "Beta-catenin independent WNT signaling"}, {"id": "R-HSA-4086398", "name": "Ca2+ pathway"}, {"id": "R-HSA-418990", "name": "Adherens junctions interactions"}, {"id": "R-HSA-418990", "name": "Adherens junctions interactions"}, {"id": "R-HSA-421270", "name": "Cell-cell junction organization"}, {"id": "R-HSA-421270", "name": "Cell-cell junction organization"}, {"id": "R-HSA-426486", "name": "Small interfering RNA (siRNA) biogenesis"}, {"id": "R-HSA-426496", "name": "Post-transcriptional silencing by small RNAs"}, {"id": "R-HSA-446728", "name": "Cell junction organization"}, {"id": "R-HSA-446728", "name": "Cell junction organization"}, {"id": "R-HSA-5578749", "name": "Transcriptional regulation by small RNAs"}, {"id": "R-HSA-5628897", "name": "TP53 Regulates Metabolic Genes"}, {"id": "R-HSA-5663202", "name": "Diseases of signal transduction by growth factor receptors and second messengers"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5687128", "name": "MAPK6/MAPK4 signaling"}, {"id": "R-HSA-6807070", "name": "PTEN Regulation"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8878171", "name": "Transcriptional regulation by RUNX1"}, {"id": "R-HSA-8934593", "name": "Regulation of RUNX1 Expression and Activity"}, {"id": "R-HSA-8939211", "name": "ESR-mediated signaling"}, {"id": "R-HSA-8943723", "name": "Regulation of PTEN mRNA translation"}, {"id": "R-HSA-8948700", "name": "Competing endogenous RNAs (ceRNAs) regulate PTEN translation"}, {"id": "R-HSA-8986944", "name": "Transcriptional Regulation by MECP2"}, {"id": "R-HSA-8986944", "name": "Transcriptional Regulation by MECP2"}, {"id": "R-HSA-9006925", "name": "Intracellular signaling by second messengers"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9006936", "name": "Signaling by TGFB family members"}, {"id": "R-HSA-9018519", "name": "Estrogen-dependent gene expression"}, {"id": "R-HSA-9022692", "name": "Regulation of MECP2 expression and activity"}, {"id": "R-HSA-9024446", "name": "NR1H2 and NR1H3-mediated signaling"}, {"id": "R-HSA-9029569", "name": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux"}, {"id": "R-HSA-9634815", "name": "Transcriptional Regulation by NPAS4"}, {"id": "R-HSA-9700206", "name": "Signaling by ALK in cancer"}, {"id": "R-HSA-9725370", "name": "Signaling by ALK fusions and activated point mutants"}, {"id": "R-HSA-9725371", "name": "Nuclear events stimulated by ALK signaling in cancer"}, {"id": "R-HSA-9730414", "name": "MITF-M-regulated melanocyte development"}, {"id": "R-HSA-9759475", "name": "Regulation of CDH11 Expression and Function"}, {"id": "R-HSA-9759475", "name": "Regulation of CDH11 Expression and Function"}, {"id": "R-HSA-9759476", "name": "Regulation of Homotypic Cell-Cell Adhesion"}, {"id": "R-HSA-9759476", "name": "Regulation of Homotypic Cell-Cell Adhesion"}, {"id": "R-HSA-9759811", "name": "Regulation of CDH11 mRNA translation by microRNAs"}, {"id": "R-HSA-9759811", "name": "Regulation of CDH11 mRNA translation by microRNAs"}, {"id": "R-HSA-9764260", "name": "Regulation of Expression and Function of Type II Classical Cadherins"}, {"id": "R-HSA-9764260", "name": "Regulation of Expression and Function of Type II Classical Cadherins"}, {"id": "R-HSA-9768759", "name": "Regulation of NPAS4 gene expression"}, {"id": "R-HSA-9768778", "name": "Regulation of NPAS4 mRNA translation"}, {"id": "R-HSA-9816359", "name": "Maternal to zygotic transition (MZT)"}, {"id": "R-HSA-9820841", "name": "M-decay: degradation of maternal mRNAs by maternally stored factors"}, {"id": "R-HSA-9824594", "name": "Regulation of MITF-M-dependent genes involved in apoptosis"}, {"id": "R-HSA-9839373", "name": "Signaling by TGFBR3"}, {"id": "R-HSA-9839394", "name": "TGFBR3 expression"}, {"id": "R-HSA-9856651", "name": "MITF-M-dependent gene expression"}], "wikipathways": [{"id": "WP2805", "name": "exRNA mechanism of action and biogenesis"}, {"id": "WP4549", "name": "Fragile X Syndrome"}, {"id": "WP4673", "name": "Male infertility"}, {"id": "WP4844", "name": "The influence of laminopathies on Wnt signaling"}, {"id": "WP4879", "name": "The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies"}]}, "pdb": ["3LUC", "3LUD", "3LUG", "3LUH", "3LUJ", "3LUK", "3QX8", "3QX9", "4F3T", "4OLA", "4OLB", "4W5N", "4W5O", "4W5Q", "4W5R", "4W5T", "4Z4C", "4Z4D", "4Z4E", "4Z4F", "4Z4G", "4Z4H", "4Z4I", "5JS1", "5JS2", "5KI6", "5T7B", "5WEA", "6CBD", "6MDZ", "6MFN", "6MFR", "6N4O", "6NIT", "6RA4", "7C6B", "7D7U", "7KI3", "8D6J", "8D71"], "pfam": ["PF02170", "PF02171", "PF08699", "PF16486", "PF16487", "PF16488"], "pharmgkb": "PA27694", "pharos": {"target_id": 61, "tdl": "Tbio"}, "prosite": ["PS50821", "PS50822"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF264235", "relationship": "is"}, {"id": "GNF264236", "relationship": "is"}, {"id": "GNF264237", "relationship": "is"}, {"id": "GNF264238", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": [{"id": "GNF160251", "relationship": "is"}, {"id": "GNF162174", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF043063", "relationship": "is"}, {"id": "GNF046557", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF004066", "relationship": "is"}, {"id": "GNF016966", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF285036", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF099875", "relationship": "is"}, {"id": "GNF139530", "relationship": "is"}, {"id": "GNF155587", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000008.11", "NC_060932.1"], "protein": ["NP_001158095.1", "NP_036286.2", "XP_011515267.1", "XP_011515270.3", "XP_047277651.1", "XP_047277652.1", "XP_047277653.1", "XP_054216272.1", "XP_054216273.1", "XP_054216274.1", "XP_054216275.1", "XP_054216276.1"], "rna": ["NM_001164623.3", "NM_012154.5", "XM_011516965.3", "XM_011516968.3", "XM_047421695.1", "XM_047421696.1", "XM_047421697.1", "XM_054360297.1", "XM_054360298.1", "XM_054360299.1", "XM_054360300.1", "XM_054360301.1"], "translation": [{"protein": "XP_011515267.1", "rna": "XM_011516965.3"}, {"protein": "XP_054216272.1", "rna": "XM_054360297.1"}, {"protein": "XP_011515270.3", "rna": "XM_011516968.3"}, {"protein": "XP_054216274.1", "rna": "XM_054360299.1"}, {"protein": "NP_001158095.1", "rna": "NM_001164623.3"}, {"protein": "XP_054216276.1", "rna": "XM_054360301.1"}, {"protein": "XP_054216273.1", "rna": "XM_054360298.1"}, {"protein": "XP_054216275.1", "rna": "XM_054360300.1"}, {"protein": "XP_047277652.1", "rna": "XM_047421696.1"}, {"protein": "NP_036286.2", "rna": "NM_012154.5"}, {"protein": "XP_047277651.1", "rna": "XM_047421695.1"}, {"protein": "XP_047277653.1", "rna": "XM_047421697.1"}]}, "reporter": {"GNF1H": ["gnf1h01409_at", "gnf1h05056_s_at", "gnf1h09155_s_at"], "HG-U133_Plus_2": ["1561042_at", "213310_at", "225569_at", "225827_at"], "HG-U95Av2": "38505_at", "HG-U95B": ["56226_at", "58633_s_at"], "HTA-2_0": ["TC08001683.hg.1", "TC08001684.hg.1", "TC08002130.hg.1"], "HuEx-1_0": "3156193", "HuGene-1_1": "8153201", "HuGene-2_1": ["17081706", "17081708"]}, "retired": 286109, "summary": "This gene encodes a member of the Argonaute family of proteins which play a role in RNA interference. The encoded protein is highly basic, and contains a PAZ domain and a PIWI domain. It may interact with dicer1 and play a role in short-interfering-RNA-mediated gene silencing. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009].", "symbol": "AGO2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414333"}, "unigene": ["Hs.743313", "Hs.660189"], "uniprot": {"Swiss-Prot": "Q9UKV8", "TrEMBL": ["E5RJY2", "E5RGG9"]}, "wikipedia": {"url_stub": "EIF2C2"}}